GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MBX Biosciences Inc (NAS:MBX) » Definitions » PB Ratio

MBX (MBX Biosciences) PB Ratio : 2.22 (As of Dec. 13, 2024)


View and export this data going back to 2024. Start your Free Trial

What is MBX Biosciences PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-13), MBX Biosciences's share price is $18.94. MBX Biosciences's Book Value per Share for the quarter that ended in Sep. 2024 was $8.52. Hence, MBX Biosciences's PB Ratio of today is 2.22.

The historical rank and industry rank for MBX Biosciences's PB Ratio or its related term are showing as below:

MBX's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.48
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


MBX Biosciences PB Ratio Historical Data

The historical data trend for MBX Biosciences's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MBX Biosciences PB Ratio Chart

MBX Biosciences Annual Data
Trend Dec22 Dec23
PB Ratio
- -

MBX Biosciences Quarterly Data
Dec22 Jun23 Sep23 Dec23 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial - - - - -

Competitive Comparison of MBX Biosciences's PB Ratio

For the Biotechnology subindustry, MBX Biosciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MBX Biosciences's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MBX Biosciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where MBX Biosciences's PB Ratio falls into.



MBX Biosciences PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

MBX Biosciences's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=18.94/8.519
=2.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


MBX Biosciences  (NAS:MBX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


MBX Biosciences PB Ratio Related Terms

Thank you for viewing the detailed overview of MBX Biosciences's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


MBX Biosciences Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11711 N. Meridian Street, Suite 300, Carmel, IN, USA, 46032
MBX Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.